| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |